Skip to main content

Canine Spectra 10

This page contains information on Canine Spectra 10 for veterinary use.
The information provided typically includes the following:
  • Canine Spectra 10 Indications
  • Warnings and cautions for Canine Spectra 10
  • Direction and dosage information for Canine Spectra 10

Canine Spectra 10

This treatment applies to the following species:
Company: Durvet

Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine

Modified Live & Killed Virus

Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona

Bacterial Extract



Canine Spectra 10 Indications

This product has been shown to be effective for the vaccination of healthy dogs 6 weeks of age or older against canine distemper (CDV), infectious canine hepatitis (CAV1), canine adenovirus type 2 (CAV2), canine coronavirus (CCV), canine parainfluenza (CPIV), canine parvovirus (CPV), Leptospira canicola, L. icterohaemorrhagiae, L. grippotyphosa, and L. pomona. The duration of immunity has not been determined. For more information regarding efficacy and safety data go to


Canine Spectra® 10 vaccine is a combination of immunogenic, attenuated strains of CDV, CAV2, CPIV, and CPV type 2b, propagated in cell line tissue cultures. The diluent contains killed CCV with Leptospira bacterial antigens. The CAV2 fraction has been shown to be effective against disease due to CAV1. The CPV2b strain has been demonstrated to be effective against CPV2c in puppies with CPV maternal antibody. Gentamicin and thimerosal added as preservatives.

Directions and dosage: Open the syringe by twisting or tapping the cap against a hard surface to break the heat weld. Aseptically rehydrate the vaccine cake with 1 mL of vaccine diluent supplied. SHAKE WELL. Withdraw entire contents into the syringe. Administer one 1 mL dose subcutaneously. Subcutaneous administration: Lift the loose skin behind the neck or behind the front leg and insert needle (see illustration, arrows 1 and 2). Inject entire contents of syringe. Do not inject directly into blood vessel (see note below). IMPORTANT NOTE: Before injecting vaccine, pull back slightly on syringe plunger. If blood enters the syringe freely, choose another injection site. All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later. The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.


Only vaccinate healthy animals. This product has not been tested in pregnant animals. Store in the dark at 35°-46°F (2°-8°C). DO NOT FREEZE. Do not mix with other products, except as specified on the label. In case of anaphylactoid reaction, administer epinephrine. Inactivate all unused contents before disposal. In case of human exposure, contact a physician.

Produced by:

Elanco US Inc., Fort Dodge, IA 50501 USA

VLN/PCN 196/46J9.29

Distributed by:

Peak Marketing, Blue Springs, MO 64013 USA

Phone: 1-800-821-5570

Canine Spectra® is a registered trademark of Durvet, Inc.


One Dose with Syringe

Package contains a one dose vial of vaccine, a one mL vial of vaccine diluent, & one disposable syringe



CPN: 1084356.3

Telephone:   816-229-9101
Toll-Free:   800-821-5570
Fax:   816-224-3080
Every effort has been made to ensure the accuracy of the Canine Spectra 10 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2021 Animalytix LLC. Updated: 2021-10-04